Possible contribution of indomethacin to the carcinogenicity of nongenotoxic bladder carcinogens that cause bladder calculi

Drug and Chemical Toxicology

Volumn 30, Issue 3, 2007, Pages 161-166

  Milman, Harry A ^a  

^a ToxNetworkcom   (United States)

Author keywords

Bladder; Calculi; Carcinogens; Indomethacin; Nongenotoxic; Terephthalic acid

Indexed keywords

CARCINOGEN; INDOMETACIN;

ARTICLE; BLADDER STONE; CARCINOGENICITY; CELL PROTECTION; DISEASE ASSOCIATION; IN VITRO STUDY; NONHUMAN; PROSTAGLANDIN SYNTHESIS;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; CYCLOOXYGENASE INHIBITORS; HUMANS; INDOMETHACIN; PROSTAGLANDINS; RISK ASSESSMENT; URINARY BLADDER CALCULI; URINARY BLADDER NEOPLASMS;

EID: 34347379505     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540701374722     Document Type: Article

References (28)

1. Burin, G. J., Gibb, H. J., Hill, R. N. (1995). Human bladder cancer: evidence for a potential irritation-induced mechanism. Food Chem. Toxicol. 33(9):785-795.
2. Cetinel, S., Cetinel, B., Ercan, F., Hrda, C., San, T. (2003). Indomethacin-induced morphologic changes in the rat urinary bladder epithelium. Urology. 61(1):236-242.
3. Cheng, L. (1980). Urinary tract calculi in man and laboratory animals: incidence, composition and etiology. J. Environ. Pathol. Toxicol. 4:317-349.
4. Clayson, D. B., Cooper, E. H. (1970). Cancer of the urinary tract. In: Greenstein, J. P., Hadlow, A., eds. Advances in Cancer Research vol. 13. New York: Academic Press, pp. 271-381.
5. Consensus Report. (1999). Species differences in thyroid, kidney and urinary bladder carcinogenesis. IARC Sci. Publ. 147:1-15.
6. Dybing, E., Sanner, T. (1999). Species differences in chemical carcinogenesis of the thyroid gland, kidney and urinary bladder. IARC Sci. Publ. 147:15-32.
7. Flaks, B., Flaks, A., Shaw, A. P. (1985). Induction by paracetamol of bladder and liver tumours in the rat. Effect on hepatocyte fine structure. Acta Pathol. Microbiol. Immunol. Scand. Sect. A. 93(6):367-377.
8. Flower, R. J. (1974). Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev. 26(1):33-67.
9. Fukushima, S., Cohen, S. M. (1980). Saccharin-induced hyperplasia of the rat urinary bladder. Cancer Res. 40(3):734-736.
10. Fukushima, S., Tanaka, H., Asakawa, E., Kagawa, M., Yamamoto, A., Shirai, T. (1992). Carcinogenicity of uracil, a nongenotoxic chemical, in rats and mice and its rationale. Cancer Res. 52(7):1675-1680.
11. Gross, J. (1974). The Effects of Prolonged Feeding of Terephthalic Acid (TPA) to Rats. Project FG-Is-175. Washington, DC: Agricultural Research Service, U.S. Department of Agriculture.
12. Hartge, P., Silverman, D., Hoover, R., Schairer, C., Altman, R., Austin, D., Cantor, K., Child, M., Key, C., Marrett, L. D., et al. (1987). Changing cigarette habits and bladder cancer risk: a case-controlled study. J. Natl. Cancer Inst. 78 (6):1119-1125.
13. Heck, H. D., Tyl, R. W. (1985). The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-8- triazine) and its relevance to risk assessment. Regul. Toxicol. Pharmacol. 5(3):294-313.
14. Holmang, S., Cano, M., Grenabo, L., Hedelin, H., Johansson, S. L. (1995). Effect of indomethacin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced urinary tract carcinogenesis. Carcinogenesis 16(7):1493-1498.
15. Holmang, S., Grenabo, L., Hedelin, H., Wang, Y. H., Pettersson, S. (1991). Influence of indomethacin on the adherence of urease-induced crystals to rat bladder epithelium. J. Urol. 145(1):176-178.
16. Huff, J. (1999). Chemicals associated with tumours of the kidney, urinary bladder and thyroid gland in laboratory rodents from 2000 US National Toxicology Program/National Cancer Institute bioassays for carcinogenicity. IARC Sci. Publ. 147:211-225.
17. Huff, J. (2002). IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer. Int. J. Occup. Environ. Health 8(3):249-270.
18. Ito, N., Fukushima, S., Shirai, T., Hagiwara, A., Imaida, K. (1984). Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis. IARC Sci. Publ. 56:399-407.
19. Jeremy, J. Y., Mikhailidis, D. P., Dandona, P. (1985). Cigarette smoke extracts inhibit prostacyclin synthesis by the rat urinary bladder. Br. J. Cancer 51(6):837-842.
20. Johansson, S. L. (1981). Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetaminophen). Int. J. Cancer 27(4):521-529.
21. Jull, J. W. (1951). The induction of tumours of the bladder epithelium in mice by the direct application of a carcinogen. Br. J. Cancer 5(3):328-330.
22. Jull, J. W. (1979). The effect of time on the incidence of carcinomas obtained by the implantation of paraffin wax pellets into mouse bladder. Cancer Lett. 6(1):21-25.
23. Konturek, S. J., Obtulowicz, W., Kwiecien, N., Oleksy, J. (1984). Generation of prostaglandins in gastric mucosa of patients with peptic ulcer disease: effect of nonsteroidal anti-inflammatory compounds. Scand. J. Gastroenterol. Suppl. 101:75-77.
24. Kryger, J. V., Messing, E. (1996). Bladder cancer screening. Semin. Oncol. 23(5):585-597.
25. LaVecchia, C., Airoldi, L. (1999). Human bladder cancer: epidemiological, pathological and mechanistic aspects. IARC Sci. Publ. 147:139-157.
26. Melnick, R. L., Boorman, G. A., Haseman, J. K., Montali, R. J., Huff, J. (1984). Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol. Appl. Pharamacol. 72(2):292-303.
27. Mohiuddin, J., Prentice, H. G., Schey, S., Blacklock, H., Dandona, P. (1984). Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. Ann. Intern. Med. 101(1):142.
28. Rodent Bladder Carcinogenesis Working Group. (1995). Urinary bladder carcinogenesis: implications for risk assessment. Food Chem. Toxicol. 33(9):797-802.